Literature DB >> 1937955

Expression of lactoferrin in human stomach.

Y A Luqmani1, T A Campbell, C Bennett, R C Coombes, I M Paterson.   

Abstract

The expression of the haeme-binding protein, lactoferrin, was studied in human gastric tissues displaying normal, benign hyperplastic or malignant histology. A single 2.5-kb mRNA was detected in only 14% (2/14) of normal resections. This was similar to the finding that 85% of tumours were also negative, with 4/27 positive. In contrast, samples with superficial or atrophic gastritis had a high frequency of expression, with 5/7 and 9/14 positive respectively. The higher incidence of lactoferrin mRNA in antral samples was a reflection of the greater proportion of these compared with body resections of patients with gastritis. No expression was seen in any of 5 gastric carcinoma cell lines. High levels were observed in the cardia, in contrast to complete absence in the oesophagus. Immunocytochemistry showed localization of lactoferrin in cells of both antral and body glands. Chief cells, but not adjacent parietal cells, were strongly stained. In tissues exhibiting superficial or atrophic gastritis we observed a greater degree and intensity of staining as compared with samples with normal histology. We also observed some staining of tumour cells, though this was very patchy. Lactoferrin may have a role in mucosal iron transport in both normal and highly proliferating tissue, but does not appear to be significantly associated with malignant lesions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1937955     DOI: 10.1002/ijc.2910490510

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

Review 1.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  Identification, characterization, and immunogenicity of the lactoferrin-binding protein from Helicobacter pylori.

Authors:  L Dhaenens; F Szczebara; M O Husson
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

Review 3.  Helicobacter pylori infection and extragastric disorders in children: a critical update.

Authors:  Lucia Pacifico; John F Osborn; Valeria Tromba; Sara Romaggioli; Stefano Bascetta; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

4.  Antibiotic properties of bovine lactoferrin on Helicobacter pylori.

Authors:  E J Dial; L R Hall; H Serna; J J Romero; J G Fox; L M Lichtenberger
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

5.  Refractory iron-deficiency anaemia due to silent Helicobacter pylori gastritis in children.

Authors:  Maria Kostaki; Smaragdi Fessatou; Themistocles Karpathios
Journal:  Eur J Pediatr       Date:  2003-01-23       Impact factor: 3.183

6.  Iron acquisition by Helicobacter pylori: importance of human lactoferrin.

Authors:  M O Husson; D Legrand; G Spik; H Leclerc
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

7.  Gene expression profiling in gastric mucosa from Helicobacter pylori-infected and uninfected patients undergoing chronic superficial gastritis.

Authors:  Ze-Min Yang; Wei-Wen Chen; Ying-Fang Wang
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

8.  Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps.

Authors:  Florent Ailloud; Xavier Didelot; Sabrina Woltemate; Gudrun Pfaffinger; Jörg Overmann; Ruth Christiane Bader; Christian Schulz; Peter Malfertheiner; Sebastian Suerbaum
Journal:  Nat Commun       Date:  2019-05-22       Impact factor: 14.919

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.